Incidence of Recraniotomy for Postoperative Infections After Surgery for Intracranial Tumors

 

N

%

Patients

2,630

100

Sex

 Male

1,275

48.5

 Female

1,355

51.5

Age (years)

 18–29.9

141

5.4

 30–39.9

300

11.4

 40–49.9

437

16.6

 50–59.9

604

23.0

 60–69.9

649

24.7

 70–79.9

411

15.6

 >80

88

3.3

Type of surgery

 Primary

2,141

81.4

 Second

489

18.6

Craniotomy

 Resection

2,556

97.2

 Open biopsy

74

2.8

Main histology

 High-grade glioma (HGG)

830

31.6

 Meningioma

693

26.3

 Metastases

449

17.1

 Low-grade glioma (LGG)

289

11.0

 Schwannoma

73

2.8

 Primary CNS-lymphoma

51

1.9

 CNS hemangioblastoma

39

1.5

 Cavernous hemangioma

38

1.4

 Pituitary adenoma

8

0.3

 Others

160

6.1





Perioperative Craniotomy Routines


A consultant anesthetist should see all craniotomy patients preoperatively. Elderly patients (>70 years) and patients on multiple medications should routinely also seen by consultant internist, to optimize the general medical condition and medications. At our institution, a second-generation cephalosporin is administered intravenously at initiation of surgery and continued every 90 min until the case is completed or the maximum daily dose of 8 g is reached. For long cases, erythromycin or a third-generation cephalosporin is started after the maximum daily dose of a second-generation cephalosporin is reached and continued until completion of the case. Antibiotics are not routinely used in the postoperative phase.


Incidence of Craniotomies


First-time craniotomies with primary resection were performed in 2,073 cases, 483 cases were reoperations with repeated resection, and 74 cases were open biopsies. Thus, the incidence of first-time craniotomy for a brain tumor was 12.8/100,000 inhabitants per year and for a repeat resection 3.0/100,000 inhabitants per year.


Postoperative Infection Requiring Recraniotomy


A total of 39 patients (1.5 %) were reoperated for deep postoperative infection (Table 20.2). Of these infections, 23 (59.0 %) were extradural (ED), 6 (15.4 %) intradural (ID), and 10 (25.6 %) were both intra- and extradural.


Table 20.2
Patients reoperated for postoperative infection (n = 39)




























































































































































































































































Age

Sex

ASA

ECOG

Immune compromise

Histologya

Locationb

Time to reop. (days)c

Outcomed

18

M

2

2


HGG

ED

16

NAD

40

M

2

3


HGG

ED

46

NAD

57

M

NA

1


HGG

ED

20

NAD

59

M

3

3


HGG

ED

307

NAD

64

M

3

3


HGG

ED

49

Death

69

M

3

3

Diabetes

HGG

ED

80

Major

70

M

2

1


HGG

ED

20

NAD

70

F

2

1


HGG

ID

25

NAD

34

M

2

2

HIV

Lymfoma

ED

667

NAD

26

F

1

1


Meningioma

ED

71

NAD

33

F

2

1


Meningioma

ED

119

NAD

38

M

2

1


Meningioma

ED

248

NAD

40

F

1

1


Meningioma

ED

270

NAD

42

F

1

1


Meningioma

ED/ID

25

Minor

49

M

2

1


Meningioma

ED/ID

29

NAD

51

M

3

1


Meningioma

ID

31

NAD

53

F

2

1


Meningioma

ED

42

NAD

55

M

2

1


Meningioma

ED

18

NAD

56

M

3

1

Diabetes

Meningioma

ID

45

NAD

56

F

NA

1


Meningioma

ED/ID

38

Minor

56

M

2

1


Meningioma

ED

35

NAD

58

M

3

1


Meningioma

ED

59

NAD

64

M

2

1


Meningioma

ID

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Mar 17, 2017 | Posted by in NEUROLOGY | Comments Off on Incidence of Recraniotomy for Postoperative Infections After Surgery for Intracranial Tumors

Full access? Get Clinical Tree

Get Clinical Tree app for offline access